AI assistant
Sending…
Salarius Pharmaceuticals, Inc. — Director's Dealing 2019
Jul 24, 2019
35494_dirs_2019-07-23_caaa76db-bfd9-4ae6-8493-3d84faa770fb.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Salarius Pharmaceuticals, Inc. (SLRX)
CIK: 0001615219
Period of Report: 2019-07-19
Reporting Person: Burleson Tess (Director)
More from Salarius Pharmaceuticals, Inc.
Regulatory Filings
2026
May 19
Annual Report
2026
Apr 30
Regulatory Filings
2026
Apr 2
Regulatory Filings
2026
Apr 2
Regulatory Filings
2026
Feb 25
Major Shareholding Notification
2026
Feb 17
Proxy Solicitation & Information Statement
2026
Jan 9
Regulatory Filings
2026
Jan 8
Regulatory Filings
2026
Jan 2
Director's Dealing
2026
Jan 2